Overview
Atomoxetine is a non-stimulant medication specifically approved for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children, adolescents and adults.

Mechanism of Action
Unlike stimulants, it is a highly selective noradrenaline reuptake inhibitor. By blocking the noradrenaline transporter, it increases noradrenaline levels in the prefrontal cortex, which is associated with improved attention and behaviour control.

Dosage and Administration
Administered orally once or twice daily. The dosage is typically based on body weight for children and adolescents. It does not have the abuse potential of stimulant medications and is not a controlled substance.

Side Effects
Common side effects include upset stomach, feeling sick, reduced appetite, tiredness and dizziness. In rare cases, it carries a warning for potential serious liver damage and a possible increased risk of suicidal thoughts in children and adolescents.

Contraindications
Contraindicated in patients with narrow-angle glaucoma, phaeochromocytoma, or severe cardiovascular disorders. It must not be used within 14 days of taking a monoamine oxidase inhibitor (MAOI).